Found: 2
Select item for more details and to access through your institution.
Bortezomib consolidation post‐ASCT as frontline therapy for multiple myeloma deepens disease response and MRD‐negative rate whilst maintaining QOL and response to re‐treatment at relapse.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 948, doi. 10.1111/bjh.15649
- By:
- Publication type:
- Article
A Novel Requirement for Janus Kinases as Mediators of Drug Resistance Induced by Fibroblast Growth Factor-2 in Human Cancer Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 5, p. 1, doi. 10.1371/journal.pone.0019861
- By:
- Publication type:
- Article